Protein kinases and kinase-modulated effectors in the late phase of ischemic preconditioning

被引:48
作者
Baines, CP
Pass, JM
Ping, PP
机构
[1] Univ Louisville, Dept Med, Div Cardiol, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Phys & Biophys, Louisville, KY 40202 USA
关键词
cardioprotection; protein kinases; signal transduction; stress proteins; signaling complex;
D O I
10.1007/s003950170051
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the 15 years since the first publication on ischemic preconditioning (PC), our knowledge of this phenomenon has increased exponentially. While the original studies described the early phase of ischemic PC, we now know that a second or late phase of ischemic PC also exists. In particular, the late phase of PC is triggered by factors such as adenosine, opioids, radicals, and nitric oxide. These factors in turn initiate a molecular chain reaction, which includes activation of serine/threonine kinases, tyrosine kinases, and mitogen-activated protein kinases. Subsequently, this cascade of reactions modulates a plethora of cardioprotective proteins including heat shock proteins, K-ATP channels, nitric oxide synthase, cyclooxygenase-2, and antioxidants. However, despite this phenomenal amount of information, the construction of a unifying hypothesis describing the signaling mechanism of late PC has proved challenging. The purpose of this article, therefore, is to review the current literature and hypothesis regarding the signaling system in the late phase of ischemic PC, to tackle areas of controversy within this model, and to address potential future directions of investigation that will hopefully promote the generation of a unifying paradigm.
引用
收藏
页码:207 / 218
页数:12
相关论文
共 96 条
[51]  
Martin JL, 1999, GENE EXPRESSION, V7, P349
[52]  
Martin JL, 1997, CIRCULATION, V96, P4343
[53]   Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts [J].
Maulik, N ;
Watanabe, M ;
Zu, YL ;
Huang, CK ;
Cordis, GA ;
Schley, JA ;
Das, DK .
FEBS LETTERS, 1996, 396 (2-3) :233-237
[54]   β-Arrestin 2:: A receptor-regulated MAPK scaffold for the activation of JNK3 [J].
McDonald, PH ;
Chow, CW ;
Miller, WE ;
Laporte, SA ;
Field, ME ;
Lin, FT ;
Davis, RJ ;
Lefkowitz, RJ .
SCIENCE, 2000, 290 (5496) :1574-1577
[55]   The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical [J].
Mocanu, MM ;
Baxter, GF ;
Yue, Y ;
Critz, SD ;
Yellon, DM .
BASIC RESEARCH IN CARDIOLOGY, 2000, 95 (06) :472-478
[56]  
MOCKRIDGE JW, 2000, J MOL CELL CARDIOL, V32, pA19
[57]   PRECONDITIONING WITH ISCHEMIA - A DELAY OF LETHAL CELL INJURY IN ISCHEMIC MYOCARDIUM [J].
MURRY, CE ;
JENNINGS, RB ;
REIMER, KA .
CIRCULATION, 1986, 74 (05) :1124-1136
[58]   SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts [J].
Nakano, A ;
Cohen, MV ;
Critz, S ;
Downey, JM .
BASIC RESEARCH IN CARDIOLOGY, 2000, 95 (06) :466-471
[59]   Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart - Evidence for involvement of p38 MAPK [J].
Nakano, A ;
Baines, CP ;
Kim, SO ;
Pelech, SL ;
Downey, JM ;
Cohen, MV ;
Critz, SD .
CIRCULATION RESEARCH, 2000, 86 (02) :144-151
[60]   Gαi and Gαo are target proteins of reactive oxygen species [J].
Nishida, M ;
Maruyama, Y ;
Tanaka, R ;
Kontani, K ;
Nagao, T ;
Kurose, H .
NATURE, 2000, 408 (6811) :492-495